Your browser doesn't support javascript.
loading
Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?
Kong, Jee Hyun; Winton, Elliott F; Heffner, Leonard T; Chen, Zhengjia; Langston, Amelia A; Hill, Brittany; Arellano, Martha; El-Rassi, Fuad; Kim, Audrey; Jillella, Anand; Kota, Vamsi K; Bodó, Imre; Khoury, Hanna Jean.
Afiliación
  • Kong JH; Division of Hematology-Oncology, Department of Internal Medicine, Wonju Severance Hospital, Yonsei College of Medicine, Wonju, Korea.
  • Winton EF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Heffner LT; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Chen Z; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Langston AA; Department of Biostatistics and Bioinformatics, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Hill B; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Arellano M; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • El-Rassi F; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Kim A; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Jillella A; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Kota VK; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Bodó I; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Khoury HJ; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
Cancer ; 123(13): 2482-2488, 2017 Jul 01.
Article en En | MEDLINE | ID: mdl-28241101
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Fusión bcr-abl / Inhibidores de Proteínas Quinasas / Espera Vigilante / Deprescripciones / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies Idioma: En Revista: Cancer Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Fusión bcr-abl / Inhibidores de Proteínas Quinasas / Espera Vigilante / Deprescripciones / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies Idioma: En Revista: Cancer Año: 2017 Tipo del documento: Article